CorMedix (CRMD) Stock Research, Analysis & News

Quick Analysis on CorMedix (CRMD) Stock as of April 29, 2017

Previous Closing Price $1.04 is below its 50 day moving average $1.47
Previous Closing Price $1.04 is below its 200 day moving average $1.82
The Stock pays no dividend
The closing price $1.04 is more than 404.81% away from its one year target price of $5.2500
Current Short Ratio 29.7600 is great than 1
Earning per Share $-0.6490 is negative. CorMedix is lossing money.
EBITDA $-24.74M is negative
It is a very small cap stock with market cap of $25.81M
(See more information about CorMedix (CRMD) Stock below)

CorMedix (CRMD) Stock Profile Summary

CorMedix, Inc., a development-stage biopharmaceutical company, develops, manufactures, and markets products that lock a patient's central venous catheter between hemodialysis sessions to keep it free of infection and clots. It provides CMX001 that reduces oxidative stress due to excess labile iron; CMX002, a diagnostic test for chronic kidney disease; CMX003, an antimicrobial/anticoagulant solution; and CMX004, a pressure-sensitive gel. The company was incorporated in 2006 and is based in Bridgewater, New Jersey.

CorMedix (CRMD) Stock Key Statistics Research and Analysis as of April 29, 2017

Stock ExchangeASE
Market Capitalization$25.81M
Trade Volume (Average Trading Volume)3,499,375 (299,659)
Current Year EPS Estimate$-0.6500
Next Year EPS Estimate$-0.5600
Previous Closing Price$1.04
50 Day Price Moving Average$1.47
200 Day Price Moving Average$1.82
1 yr Target Price$5.2500
PEG Ratio0.0000
Short Ratio29.7600

CorMedix (CRMD) Stock Competitor Research and Analysis

Amgen Inc. (AMGN)Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)Novartis AG (NVS)
AstraZeneca PLC (AZN)Abbott Laboratories (ABT)
Bristol-Myers Squibb Company (BMY)

Stock Research on CorMedix (CRMD)

Latest Market News on CorMedix (CRMD)

Click here to find the latest news on CorMedix (CRMD)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)
AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)
Bristol-Myers Squibb Company (BMY)